Novel SHV-derived extended-spectrum β-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 600-605

  Ma, Ling ^a   Alba, Jimena ^c   Chang, Feng Yee ^b   Ishiguro, Masaji ^d   Yamaguchi, Keizo ^c   Siu, L K ^a   Ishii, Yoshikazu ^c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TOHO UNIVERSITY   (Japan)

^d SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA LACTAMASE SHV 1; BETA LACTAMASE SHV 57; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; IMIPENEM; NITROCEFIN; PENICILLIN G; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BINDING AFFINITY; CATALYSIS; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENE IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL;

BETA-LACTAMASES; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORINS; CLONING, MOLECULAR; CONJUGATION, GENETIC; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; INFANT; ISOELECTRIC FOCUSING; KINETICS; MALE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PLASMIDS; TAIWAN;

EID: 12944291456     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.600-605.2005     Document Type: Article

References (20)

1. Alba, J., C. Bauvois, Y. Ishii, M. Galleni, K. Masuda, M. Ishiguro, M. Ito, J. M. Frere, and K. Yamaguchi. 2003. A detailed kinetic study of MOX-1, a plasmid-encoded class C beta-lactamase. FEMS Microbiol. Lett. 225:183-188.
2. Arlet, G., M. Rouveau, D. Bengoufa, M. H. Nicolas, and A. Philippon. 1991. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime. FEMS Microbiol. Lett. 65:57-62.
3. Bonomo, R. A., S. D. Rudin, and D. M. Shlaes. 1997. OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidime. FEMS Microbiol. Lett. 152:275-278.
4. Herzberg, O. 1991. Refined crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.0 Å resolution. J. Mol. Biol. 217:701-719.
5. Herzberg, O., G. Kapadia, B. Blanco, T. S. Smith, and A. Coulson. 1991. Structural basis for the inactivation of the P54 mutant of beta-lactamase from Staphylococcus aureus PC1. Biochemistry 30:9503-9509.
6. Herzberg, O., and J. Moult. 1987. Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphyhcoccus aureus PC1 at 2.5 Å resolution. Science 236:694-701.
7. Ho, M., L. C. McDonald, T. L. Lauderdale, L. L. Yeh, P. C. Chen, and Y. R. Shiau. 1999. Surveillance of antibiotic resistance in Taiwan, 1998. J. Microbiol. Immunol. Infect. 32:239-249.
8. Hujer, A. M., K. M. Hujer, and R. A. Bonomo. 2001. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance. Biochim. Biophys. Acta 1547:37-50.
9. Jelsch, C., L. Mourey, J. M. Masson, and J. P. Samama. 1993. Crystal structure of Escherichia coli TEM1 beta-lactamase at 1.8 Å resolution. Proteins 16:364-383.
10. Kliebe, C., B. A. Nies, J. F. Meyer, R. M. Tolxdorff-Neutzling, and B. Wiedemann. 1985. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28:302-307.
11. Knothe, H., P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317.
12. Knox, J. R., and P. C. Moews. 1991. Beta-lactamase of Bacillus licheniformis 749/C. Refinement at 2 Å resolution and analysis of hydration. J. Mol. Biol. 220:435-455.
13. Kuzin, A. P., M. Nukaga, Y. Nukaga, A. Hujer, R. A. Bonomo, and J. R. Knox. 2001. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam. Biochemistry 40:1861-1866.
14. Matthew, M., and A. M. Harris. 1976. Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J. Gen. Microbiol. 94:55-67.
15. Mercier, J., and R. C. Levesque. 1990. Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase. Antimicrob. Agents Chemother. 34:1577-1583.
16. National Committee for Clinical Laboratory Standards. 2002. Performance standards for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Raquet, X., J. Lamotte-Brasseur, E. Fonze, S. Goussard, P. Courvalin, and J. M. Frere. 1994. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis. J. Mol. Biol. 244:625-639.
18. Siu, L. K., P. L. Ho, K. Y. Yuen, S. S. Wong, and P. Y. Chau. 1997. Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the Pribnow box. Antimicrob. Agents Chemother. 41:468-470.
19. Strynadka, N. C., H. Adachi, S. E. Jensen, K. Johns, A. Sielecki, C. Betzel, K. Sutoh, and M. N. James. 1992. Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1.7 Å resolution. Nature 359:700-705.
20. Vakulenko, S. B., M. Toth, P. Taibi, S. Mobashery, and S. A. Lerner. 1995. Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams. Antimicrob. Agents Chemother. 39:1878-1880.